In September 2016, DCEG investigators hosted a workshop on esophageal cancer co-organized by the NCI and the International Agency for Research on Cancer (IARC). The goal of the workshop was to examine the state of the science on esophageal squamous cell carcinoma (ESCC) with regard to etiology, genetic risk factors, early detection and treatment, and palliative care, and to identify gaps in our understanding and the related critical research questions. The two-day meeting began with introductions from Division Director Stephen J. Chanock, M.D., and Paul Brennan, Ph.D., of IARC. DCEG presenters included Christian Abnet, Ph.D., M.P.H., Phil Taylor, M.D., Sc.D., Alisa Goldstein, Ph.D., Arash Etemadi, M.D., Ph.D., and Sandy Dawsey, M.D.
ESCC makes up the vast majority of esophageal cancer cases worldwide. The geographic distribution is extraordinarily uneven, with high incidence regions stretching across central Asia from China to Iran, from eastern to southern Africa, and parts of South America. Topics of discussion ranged from descriptive epidemiology and genetic studies to early detection and treatment. The detailed agenda and copies of the slides used in the presentations are available on the IARC website.